Skip to main content
The BMJ logoLink to The BMJ
letter
. 2005 Jan 29;330(7485):253. doi: 10.1136/bmj.330.7485.253-b

The GMC: expediency before principle

Proceed with caution

Stephen F Hayes 1
PMCID: PMC546113  PMID: 15677667

Editor—When a new drug is introduced, three questions must be asked and as far as possible answered before it comes into widespread use:

  1. Does it work for the condition in question?

  2. Is it safe? (In particular, are there any potential side effects that may be worse than the disease?)

  3. Is it affordable?

The drug must also be compared with other agents and therapeutic approaches, and supplementary questions asked such as who stands to profit and whether the condition is self limiting or potentially lethal.

To some principle is all—that is, even if a new drug gives only a 30% improvement and costs £10 000 per patient, it must still be given. However, that £10 000 has to come from somewhere, perhaps an unsexy condition such as leg ulcers.

Dame Janet Smith's proposals are like a new drug.1 We are not entirely sure what condition is being treated. There is no evidence base or comparative trials. Potential side effects include an exodus from the profession of 50-something doctors who are “all reformed out” and a lack of bright teenagers entering such an over-managed career. Why not be a lawyer like Dame Janet rather than a doctor who can be suspended on an anonymous denunciation or lose her career for one mistake?

Shipman and Bristol did happen, and the performance of doctors matters. Laissezfaire is not an option. However, before we mass medicate, we need more evidence and a thorough analysis of risk and benefit.

This is a time for clear heads, not panic measures. And if we are talking about principle, then the principle of whether a government that started a bloody war which has made the world less safe should implement costly and potentially harmful vote-winning measures to control the medical profession is one that might be worth going to the barricades over.

Competing interests: SFH is a working doctor.

References


Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES